Central European Institute of Technology
Address: | Kamenice 753/5, 625 00 Brno, Building E35 |
---|
Phone: | +420 549 49 2911 |
---|---|
E-mail: |
Company identification number: | 00216224 |
---|---|
VAT identification number: | CZ00216224 |
Data Box ID: | 9tmj9e4 |
Bank Account: | Komerční banka, a.s., Nám. Svobody 92/21, 602 00 Brno |
---|---|
Account number/Bank ID code: 85636621/0100 | |
IBAN: CZ43 0100 0000 0000 8563 6621 | |
SWIFT (=BIC): KOMBCZPPXXX |
Total number of publications: 83
Articles
-
Structure and replication cycle of a virus infecting climate-modulating alga <i>Emiliania huxleyi</i>
Science advances, year: 2024, volume: 10, edition: 15, DOI
-
Successful asymmetrical deep brain stimulation using right subthalamic and left pallidal electrodes in a patient with Parkinson's disease
British journal of neurosurgery, year: 2024, DOI
-
TeloBase: a community-curated database of telomere sequences across the tree of life
Nucleic Acids Research, year: 2024, volume: 52, edition: D1, DOI
-
The impact of ortho-substituents on Bonding in Silver(I) and Halogen(I) complexes of 2-Mono- and 2,6-Disubstituted Pyridines: An In-depth Experimental and Theoretical Study
Chemistry - A European Journal, year: 2024, volume: 30, edition: 13, DOI
-
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib
Leukemia, year: 2024, DOI
-
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment
Clinical Gastroenterology and Hepatology, year: 2024, DOI
-
Unilateral hippocampal sparing during whole brain radiotherapy for multiple brain metastases: narrative and critical review
Frontiers in Oncology, year: 2024, volume: 14, edition: January 2024, DOI
-
Weak coupling of neurons enables very high-frequency and ultra-fast oscillations through the interplay of synchronized phase-shifts
Network Neuroscience, year: 2024, volume: 8, edition: 1, DOI
-
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF
Leukemia, year: 2024, DOI
-
YAP Signaling Regulates the Cellular Uptake and Therapeutic Effect of Nanoparticles
Advanced Science, year: 2024, volume: 11, edition: 2, DOI